期刊文献+

23F型肺炎链球菌多糖蛋白结合物游离蛋白含量检测方法的建立及验证 被引量:2

Development and validation of a method for determination of free protein content in type 23F pneumococcal polysaccharide conjugate
原文传递
导出
摘要 目的建立一种检测23F型肺炎链球菌多糖结合物游离蛋白含量的方法,并进行方法学验证。方法采用体积排阻高效液相色谱(size exclusion chromatography and high performance liquid chromatography,SEC-HPLC)法检测23F型肺炎链球菌多糖结合物游离蛋白含量。色谱柱:TSKgel G3000(300 mm×78 mm,5μm);流动相:10 mmol/L PBS(150 mmol/L NaCl,pH 6. 8);检测波长:214 nm;流速:0. 5 m L/min;柱温:25℃;自动进样:100μL。同时对该方法进行线性、精密度、准确度、耐用性及专属性验证。结果建立的方法在纯化载体蛋白破伤风类毒素(tetanus toxoid,TT)含量为3~18μg/mL时,与峰面积呈良好的线性关系,线性相关系数(R2)> 0. 99;23F-2017001、23F-2017002、23F-2017003批供试品重复性相对标准偏差(RSD)分别为0. 1%、0. 3%、1. 0%,中间精密性RSD分别为3. 7%、8. 5%、4. 8%;加入6、8、10μg/mL纯化载体蛋白TT样品的3次检测结果回收率在93. 2%~102. 6%之间,回收率的RSD均为0. 6%;进样温度为20~30℃条件下的保留时间和峰面积相对偏倚在-0. 1%~0. 5%之间;流动相溶液中含甘氨酸及低浓度硼酸时对检测结果无干扰,硼酸浓度为20 mmol/L以上时对游离蛋白峰检测有一定干扰。结论本实验建立的方法具有良好的线性、精密性、准确性、耐用性及专属性,可用于23F型肺炎链球菌多糖结合物游离蛋白含量检测。 Objective To develop and validate a method for determination of free protein content in type 23F pneumococcal polysaccharide conjugate. Methods The free protein content in type 23 F pneumococcal polysaccharide conjugate was determined by size exclusion chromatography and high performance liquid chromatography(SEC-HPLC).TSKgel G3000(300 mm × 78 mm,5 μm)was used serving 10 mmol/L PBS containing 150 mmol/L sodium chloride(pH 6. 8)as mobile phase at a flow rate of 0. 5 mL/min,a detection wavelength of 214 nm and a temperature of 25 ℃.The volume of sample for loading was 100 μL. The developed method was validated for linearity,precision,accuracy,durability and specificity. Results The content of purified tetanus toxoid(TT)determined by the method,at a range of 3 ~ 18 μg/mL,showed good linear relationship to the peak area,with a linear correlation coefficient(R2 value)of more than 0. 99. The RSDs of reproducibility test results of samples with lot numbers of 23 F-2017001,23 F-2017002 and 23 F-2017003 were 0. 1%,0. 3% and 1. 0%,while those of intermediate precision test results were 3. 7%,8. 5% and 4. 8%,respectively. The recoveries of samples added with 6,8 and 10 μg/mL purified TT were 93. 2%~ 102. 6%,each with a RSD of 0. 6%. The relative biases of retention time and peak area at temperature for sample loading of 20 ~ 30 ℃ were-0. 1%~ 0. 5%. The glycine and low concentration boric acid in mobile phase showed no interference to test result.However,the boric acid at a concentration of more than 20 mmol/L showed a certain interference to free protein peak.Conclusion The developed method showed good linearity,precision,accuracy,durability and specificity,which might be used for determination of free protein content in type 23 F pneumococcal polysaccharide conjugate.
作者 邓海清 尹珊珊 郝倩 顾行举 刘杨 张艳红 高宇皎 刘建凯 DENG Hai-qing;YIN Shan-shan;HAO Qian;GU Xing-ju;LIU Yang;ZHANG Yan-hong;GAO Yu-jiao;LIU Jian-kai(Center of Research and Development,Minhai Biotechnology Co.,Ltd.,Beijing 102600,China)
出处 《中国生物制品学杂志》 CAS CSCD 2019年第5期579-583,共5页 Chinese Journal of Biologicals
关键词 肺炎链球菌 多糖蛋白结合物 游离蛋白 体积排阻高效液相色谱 Streptococcus pneumonia Polysaccharide and protein conjugate Free protein Size exclusion chromatography and high performance liquid chromatography(SEC-HPLC)
  • 相关文献

参考文献4

二级参考文献52

  • 1国家食品药品监督管理局.结合疫苗质量控制和临床研究技术指导原则.2005-10-14. 被引量:2
  • 2世界卫生组织.C群脑膜炎球菌结合疫苗生产和控制规程.世界卫生组织技术报告,2004,924:17. 被引量:1
  • 3Dagan R,Poolman J,Siegrist CA.Glycoconjugate vaccines andimmune interference:a review[J].Vaccine,2010,28(34):5513-5523. 被引量:1
  • 4Schmitt HJ,Maechler G,Habermehl P,et al.Immunogenicity,reactogenicity,and immune memory after primary vaccinationwith a novel Haemophilus influenzae-Neisseria meningitidisserogroup C conjugate vaccine[J].Clin Vaccine Immunol,2007,14(4):426-434. 被引量:1
  • 5Nolan T,Lambert S,Roberton D,et al.A novel combinedHaemophilus influenzae type b-Neisseria meningitidis sero-groups C and Y-tetanus-toxoid conjugate vaccine is immuno-genic and induces immune memory when co-administered withDTPa-HBV-IPV and conjugate pneumococcal vaccines in in-fants[J].Vaccine,2007,25(51):8487-8499. 被引量:1
  • 6Southern J,Crowley-Luke A,Borrow R,et al.Immunogenicityof one,two or three doses of a meningococcal C conjugatevaccine conjugated to tetanus toxoid,given as a three-doseprimary vaccination course in UK infants at 2,3 and 4 monthsof age with acellular pertussis-containing DTP/Hib vaccine[J].Vaccine,2006,24(2):215-219. 被引量:1
  • 7Tejedor JC,Moro M,Ruiz-Contreras J,et al.Immunogenicityand reactogenicity of primary immunization with a hexavalentdiphtheria-tetanus-acellular pertussis-hepatitis B-inactivatedpolio-Haemophilus influenzae type B vaccine coadministeredwith two doses of a meningococcal C-tetanus toxoid conjugatevaccine[J].Pediatr Infect Dis J,2006,25(8):713-720. 被引量:1
  • 8Tejedor JC,Moro M,Ruiz-Contreras J,et al.Immunogenicityand reactogenicity of primary immunization with a novelcombined Haemophilus influenzae type b and Neisseriameningitidis serogroup C-tetanus toxoid conjugate vaccinecoadministered with a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus vaccine at 2,4 and 6 months[J].Pediatr Infect Dis J,2007,26(1):1-7. 被引量:1
  • 9Southern J,Borrow R,Andrews N,et al.Immunogenicity of areduced schedule of meningococcal group C conjugate vaccinegiven concomitantly with the prevenar and pediacel vaccines inhealthy infants in the United Kingdom[J].Clin VaccineImmunol,2009,16(2):194-199. 被引量:1
  • 10Pace D,Snape M,Westcar S,et al.A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers:a phase 3 open randomised controlled trial[J].Arch Dis Child,2008,93(11):963-970. 被引量:1

共引文献9

同被引文献7

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部